Literature DB >> 33850121

Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.

Sarah E Garnish1,2, Yanxiang Meng1,2, Akiko Koide3,4, Jarrod J Sandow1,2, Eric Denbaum3, Annette V Jacobsen1,2, Wayland Yeung5, Andre L Samson1,2, Christopher R Horne1,2, Cheree Fitzgibbon1, Samuel N Young1, Phoebe P C Smith1, Andrew I Webb1,2, Emma J Petrie1,2, Joanne M Hildebrand1,2, Natarajan Kannan5,6, Peter E Czabotar1,2, Shohei Koide7,8, James M Murphy9,10.   

Abstract

Phosphorylation of the MLKL pseudokinase by the RIPK3 kinase leads to MLKL oligomerization, translocation to, and permeabilization of, the plasma membrane to induce necroptotic cell death. The precise choreography of MLKL activation remains incompletely understood. Here, we report Monobodies, synthetic binding proteins, that bind the pseudokinase domain of MLKL within human cells and their crystal structures in complex with the human MLKL pseudokinase domain. While Monobody-32 constitutively binds the MLKL hinge region, Monobody-27 binds MLKL via an epitope that overlaps the RIPK3 binding site and is only exposed after phosphorylated MLKL disengages from RIPK3 following necroptotic stimulation. The crystal structures identified two distinct conformations of the MLKL pseudokinase domain, supporting the idea that a conformational transition accompanies MLKL disengagement from RIPK3. These studies provide further evidence that MLKL undergoes a large conformational change upon activation, and identify MLKL disengagement from RIPK3 as a key regulatory step in the necroptosis pathway.

Entities:  

Year:  2021        PMID: 33850121     DOI: 10.1038/s41467-021-22400-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  66 in total

1.  Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Authors:  N Holler; R Zaru; O Micheau; M Thome; A Attinger; S Valitutti; J L Bodmer; P Schneider; B Seed; J Tschopp
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects.

Authors:  K R Heimlich
Journal:  J Pharm Sci       Date:  1972-10       Impact factor: 3.534

Review 3.  Regulated necrosis in kidney ischemia-reperfusion injury.

Authors:  Aspasia Pefanis; Francesco L Ierino; James M Murphy; Peter J Cowan
Journal:  Kidney Int       Date:  2019-03-07       Impact factor: 10.612

4.  Virus inhibition of RIP3-dependent necrosis.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

5.  Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation.

Authors:  Maria Pierdomenico; Anna Negroni; Laura Stronati; Roberta Vitali; Enrica Prete; John Bertin; Peter J Gough; Marina Aloi; Salvatore Cucchiara
Journal:  Am J Gastroenterol       Date:  2013-12-10       Impact factor: 10.864

6.  RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

Authors:  James A Rickard; Joanne A O'Donnell; Joseph M Evans; Najoua Lalaoui; Ashleigh R Poh; TeWhiti Rogers; James E Vince; Kate E Lawlor; Robert L Ninnis; Holly Anderton; Cathrine Hall; Sukhdeep K Spall; Toby J Phesse; Helen E Abud; Louise H Cengia; Jason Corbin; Sandra Mifsud; Ladina Di Rago; Donald Metcalf; Matthias Ernst; Grant Dewson; Andrew W Roberts; Warren S Alexander; James M Murphy; Paul G Ekert; Seth L Masters; David L Vaux; Ben A Croker; Motti Gerlic; John Silke
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

7.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors:  Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.

Authors:  Tammo Müller; Christin Dewitz; Jessica Schmitz; Anna Sophia Schröder; Jan Hinrich Bräsen; Brent R Stockwell; James M Murphy; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Cell Mol Life Sci       Date:  2017-05-27       Impact factor: 9.261

10.  A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction.

Authors:  Joanne M Hildebrand; Maria Kauppi; Ian J Majewski; Zikou Liu; Allison J Cox; Sanae Miyake; Emma J Petrie; Michael A Silk; Zhixiu Li; Maria C Tanzer; Gabriela Brumatti; Samuel N Young; Cathrine Hall; Sarah E Garnish; Jason Corbin; Michael D Stutz; Ladina Di Rago; Pradnya Gangatirkar; Emma C Josefsson; Kristin Rigbye; Holly Anderton; James A Rickard; Anne Tripaydonis; Julie Sheridan; Thomas S Scerri; Victoria E Jackson; Peter E Czabotar; Jian-Guo Zhang; Leila Varghese; Cody C Allison; Marc Pellegrini; Gillian M Tannahill; Esme C Hatchell; Tracy A Willson; Dina Stockwell; Carolyn A de Graaf; Janelle Collinge; Adrienne Hilton; Natasha Silke; Sukhdeep K Spall; Diep Chau; Vicki Athanasopoulos; Donald Metcalf; Ronald M Laxer; Alexander G Bassuk; Benjamin W Darbro; Maria A Fiatarone Singh; Nicole Vlahovich; David Hughes; Maria Kozlovskaia; David B Ascher; Klaus Warnatz; Nils Venhoff; Jens Thiel; Christine Biben; Stefan Blum; John Reveille; Michael S Hildebrand; Carola G Vinuesa; Pamela McCombe; Matthew A Brown; Benjamin T Kile; Catriona McLean; Melanie Bahlo; Seth L Masters; Hiroyasu Nakano; Polly J Ferguson; James M Murphy; Warren S Alexander; John Silke
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

View more
  15 in total

1.  NLRP3 inflammasome activation triggers gasdermin D-independent inflammation.

Authors:  Chun Wang; Tong Yang; Jianqiu Xiao; Canxin Xu; Yael Alippe; Kai Sun; Thirumala-Devi Kanneganti; Joseph B Monahan; Yousef Abu-Amer; Judy Lieberman; Gabriel Mbalaviele
Journal:  Sci Immunol       Date:  2021-10-22

Review 2.  Looking lively: emerging principles of pseudokinase signaling.

Authors:  Joshua B Sheetz; Mark A Lemmon
Journal:  Trends Biochem Sci       Date:  2022-05-16       Impact factor: 14.264

3.  Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Authors:  Ashish Sethi; Christopher R Horne; Cheree Fitzgibbon; Karyn Wilde; Katherine A Davies; Sarah E Garnish; Annette V Jacobsen; André L Samson; Joanne M Hildebrand; Ahmad Wardak; Peter E Czabotar; Emma J Petrie; Paul R Gooley; James M Murphy
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

4.  Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure.

Authors:  Ji Cao; Jingjing Zhang; Jianan Qian; Xue Wang; Wei Zhang; Xiangfan Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-28

5.  The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs.

Authors:  Lung-Yu Liang; Michael Roy; Christopher R Horne; Jarrod J Sandow; Minglyanna Surudoi; Laura F Dagley; Samuel N Young; Toby Dite; Jeffrey J Babon; Peter W Janes; Onisha Patel; James M Murphy; Isabelle S Lucet
Journal:  Biochem J       Date:  2021-09-17       Impact factor: 3.857

6.  Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.

Authors:  Yanxiang Meng; Katherine A Davies; Cheree Fitzgibbon; Samuel N Young; Sarah E Garnish; Christopher R Horne; Cindy Luo; Jean-Marc Garnier; Lung-Yu Liang; Angus D Cowan; Andre L Samson; Guillaume Lessene; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Nat Commun       Date:  2021-11-22       Impact factor: 14.919

Review 7.  Regulation of Inflammatory Cell Death by Phosphorylation.

Authors:  Wen Xu; Yi Huang
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

8.  The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.

Authors:  Annette V Jacobsen; Catia L Pierotti; Kym N Lowes; Amanda E Au; Ying Zhang; Nima Etemadi; Cheree Fitzgibbon; Wilhelmus J A Kersten; André L Samson; Mark F van Delft; David C S Huang; Hélène Jousset Sabroux; Guillaume Lessene; John Silke; James M Murphy
Journal:  Cell Death Dis       Date:  2022-04-01       Impact factor: 9.685

9.  A proteomic perspective on TNF-mediated signalling and cell death.

Authors:  Maria C Tanzer
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

10.  The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling.

Authors:  Yu Zhang; Jia Liu; Dandan Yu; Xinxin Zhu; Xiaoyan Liu; Jun Liao; Sheng Li; Huayi Wang
Journal:  Cell Death Dis       Date:  2021-06-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.